A nurse is preparing to administer mannitol IV to a client. The nurse should monitor the client for which of the following manifestations as an expected outcome of this medication?

Choice A rationale Mannitol, an osmotic diuretic, is not directly involved in the regulation of thyroid function. Thyroid-stimulating hormone (TSH) from the pituitary gland regulates thyroxine (T4) production by the thyroid gland. Mannitol's primary mechanism of action involves creating an osmotic gradient in the renal tubules and brain, drawing water out of tissues and into the vascular space, thereby increasing urine output and decreasing cerebral edema. Choice B rationale Atrial flutter is a type of supraventricular tachycardia characterized by a rapid, regular atrial rhythm. The definitive treatment for atrial flutter involves medications such as beta-blockers or calcium channel blockers to control the ventricular rate, or procedures like cardioversion or catheter ablation. Mannitol does not possess any antiarrhythmic properties and its administration would not be expected to correct this dysrhythmia. Choice C rationale Mannitol is a hyperosmotic agent that increases the osmolality of the blood. This creates a powerful osmotic gradient, drawing excess water from the interstitial space of the brain, a process known as reverse osmosis, and into the intravascular space. This reduction in fluid volume within the brain directly lowers intracranial pressure (ICP) and cerebral edema. Choice D rationale Hemoglobin levels are determined by the body's red blood cell production and destruction, and the concentration of hemoglobin within those cells. Mannitol's action is primarily diuretic and osmotically driven, affecting fluid balance rather than erythropoiesis. While fluid shifts can transiently concentrate or dilute the blood, it does not directly increase the total body hemoglobin content. Normal hemoglobin levels are typically 13.5 to 17.5 g/dL for men and 12.0 to 15.5 g/dL for women.